Your browser doesn't support javascript.
loading
Exploring various measures of the area under the curve for the assessment of dose-proportionality and estimation of bioavailability.
Brocks, Dion R; Minthorn, Elisabeth A; Davies, Brian E.
Afiliación
  • Brocks DR; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.
  • Minthorn EA; Glaxo SmithKline Pharmaceuticals, Collegeville, PA 19426, United States.
  • Davies BE; Retired, Doylestown, PA 18901, United States.
J Pharm Pharmacol ; 76(3): 245-256, 2024 Mar 04.
Article en En | MEDLINE | ID: mdl-38262451
ABSTRACT

OBJECTIVE:

In pharmacokinetics, the area under the concentration versus time curve (AUC) extrapolated to infinity (AUC0-∞) is the preferred metric but it is not always possible to have a reliable estimate of the terminal phase half-life. Here we sought to explore the accuracy of three different area measures to accurately identify dose proportionality and bioavailability.

METHODS:

One to three compartment model simulations with different doses for dose-proportionality or different rates and/or extents of bioavailability. Area measures evaluated were AUC0-∞, to the last quantifiable concentration (AUCtlast), and to a common time value (AUCt').

RESULTS:

Under linear pharmacokinetics, AUCt' provided the most accurate measure of dose proportionality. Except for the one compartment model where AUC0-∞ provided the best predictor of the true measure, there was no clear advantage to the use of either of the three measures of AUC.

CONCLUSION:

With uncertainty about the terminal phase half-life, the use of AUCt' can be a very useful and even the preferred measure of exposure for use in assessing proportionality in exposure between doses. The choice of AUC measure in bioavailability is less clear and may depend on compartmental nature of the drug, and study parameters including assay sensitivity and sampling protocols.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Disponibilidad Biológica Tipo de estudio: Prognostic_studies Idioma: En Revista: J Pharm Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Disponibilidad Biológica Tipo de estudio: Prognostic_studies Idioma: En Revista: J Pharm Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Canadá
...